Sunshine Biopharma (SBFM) said Thursday it has raised about $2.5 million following the close of its registered direct offering of shares and pre-funded warrants to institutional investors.
The company said it will use the proceeds for general corporate purposes and working capital. Aegis Capital Corp. was the placement agent for the offering.
Price: 2.01, Change: -0.24, Percent Change: -10.76
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.